{"count": 27, "results": [{"_id": "35492586", "pmid": 35492586, "pmcid": "PMC9047873", "title": "Potential Benefits of Combined Statin and Metformin Therapy on Resistance Training Response in Older Individuals", "journal": "Front Physiol", "authors": ["Long DE", "Kosmac K", "Dungan CM", "Bamman MM", "Peterson CA", "Kern PA"], "date": "2022-04-14T00:00:00Z", "doi": "10.3389/fphys.2022.872745", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "872745", "score": 50263.56, "text_hl": "We present secondary statin analyses of data from the MASTERS trial where @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ blunted the @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@hypertrophy@@@ response in healthy participants (>65 years) following 14 weeks of progressive resistance training (PRT) when compared to identical placebo treatment (n = 94). ", "citations": {"NLM": "Long DE, Kosmac K, Dungan CM, Bamman MM, Peterson CA, Kern PA. Potential Benefits of Combined Statin and Metformin Therapy on Resistance Training Response in Older Individuals Front Physiol. 2022;13():872745. PMID: 35492586", "BibTeX": "@article{35492586, title={Potential Benefits of Combined Statin and Metformin Therapy on Resistance Training Response in Older Individuals}, author={Long DE and Kosmac K and Dungan CM and Bamman MM and Peterson CA and Kern PA}, journal={Front Physiol}, volume={13}, pages={872745}}"}}, {"_id": "35326230", "pmid": 35326230, "pmcid": "PMC8945168", "title": "Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice", "journal": "Antioxidants (Basel)", "authors": ["Choi JY", "Jang TW", "Song PH", "Choi SH", "Ku SK", "Song CH"], "date": "2022-03-18T00:00:00Z", "doi": "10.3390/antiox11030580", "meta_date_publication": "2022 Mar 18", "meta_volume": "11", "meta_issue": "3", "meta_pages": "", "score": 50258.266, "text_hl": "Histopathological analyses revealed that the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combination ameliorated the @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@hepatic hypertrophy@@@/@DISEASE_Fatty_Liver @DISEASE_MESH:D005234 @@@steatosis@@@, pancreatic endocrine/exocrine alteration, @CHEMICAL_Fats @CHEMICAL_MESH:D005223 @@@fat@@@ tissue @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@hypertrophy@@@, and @DISEASE_Fatty_Liver @DISEASE_MESH:D005234 @@@renal steatosis@@@, more than either monotherapy. ", "citations": {"NLM": "Choi JY, Jang TW, Song PH, Choi SH, Ku SK, Song CH. Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice Antioxidants (Basel). 2022 Mar 18;11(3):. PMID: 35326230", "BibTeX": "@article{35326230, title={Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice}, author={Choi JY and Jang TW and Song PH and Choi SH and Ku SK and Song CH}, journal={Antioxidants (Basel)}, volume={11}, number={3}}"}}, {"_id": "34539827", "pmid": 34539827, "pmcid": "PMC8438677", "title": "Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway", "journal": "Exp Ther Med", "authors": ["Du F", "Cao Y", "Ran Y", "Wu Q", "Chen B"], "date": "2021-11-01T00:00:00Z", "doi": "10.3892/etm.2021.10665", "meta_date_publication": "2021 Nov", "meta_volume": "22", "meta_issue": "5", "meta_pages": "1231", "score": 50256.98, "text_hl": "...Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@cardiomyocyte hypertrophy@@@. ", "citations": {"NLM": "Du F, Cao Y, Ran Y, Wu Q, Chen B. Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway Exp Ther Med. 2021 Nov;22(5):1231. PMID: 34539827", "BibTeX": "@article{34539827, title={Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway}, author={Du F and Cao Y and Ran Y and Wu Q and Chen B}, journal={Exp Ther Med}, volume={22}, number={5}, pages={1231}}"}}, {"_id": "36088302", "pmid": 36088302, "pmcid": "PMC9464374", "title": "Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials", "journal": "BMC Cardiovasc Disord", "authors": ["Kamel AM", "Sabry N", "Farid S"], "date": "2022-09-10T00:00:00Z", "doi": "10.1186/s12872-022-02845-w", "meta_date_publication": "2022 Sep 10", "meta_volume": "22", "meta_issue": "1", "meta_pages": "405", "score": 50254.684, "text_hl": "@DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@Left ventricular hypertrophy@@@ is a common finding in @SPECIES_9606 @@@patients@@@ with @DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@ischemic heart disease@@@ and is associated with mortality in @SPECIES_9606 @@@patients@@@ with @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@ (@DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@CVD@@@). @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, an antidiabetic drug, has been shown to reduce oxidative stress and left ventricular mass index (LVMI) in animal @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@hypertrophy@@@ models. ", "citations": {"NLM": "Kamel AM, Sabry N, Farid S. Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials BMC Cardiovasc Disord. 2022 Sep 10;22(1):405. PMID: 36088302", "BibTeX": "@article{36088302, title={Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials}, author={Kamel AM and Sabry N and Farid S}, journal={BMC Cardiovasc Disord}, volume={22}, number={1}, pages={405}}"}}, {"_id": "32386485", "pmid": 32386485, "title": "Novel Targets of Metformin in Cardioprotection: Beyond the Effects Mediated by AMPK.", "journal": "Curr Pharm Des", "authors": ["Bolívar S", "Noriega L", "Ortega S", "Osorio E", "Rosales W", "Mendoza X", "Mendoza-Torres E"], "date": "2021-01-01T00:00:00Z", "doi": "10.2174/1381612826666200509232610", "meta_date_publication": "2021", "meta_volume": "27", "meta_issue": "1", "meta_pages": "80-90", "score": 50252.645, "text_hl": "Clinical data suggest the direct effects of this drug on cardiac metabolism and studies in animal models showed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ activates the classical pathway of @GENE_PRKAB1 @GENE_5564 @@@AMP-activated protein kinase@@@ (@GENE_PRKAB1 @GENE_5564 @@@AMPK@@@), generating cardioprotective effects during @DISEASE_Ventricular_Remodeling @DISEASE_MESH:D020257 @@@cardiac remodeling@@@, @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@hypertrophy@@@ and @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@fibrosis@@@. ", "citations": {"NLM": "Bolívar S, Noriega L, Ortega S, Osorio E, Rosales W, Mendoza X, Mendoza-Torres E. Novel Targets of Metformin in Cardioprotection: Beyond the Effects Mediated by AMPK. Curr Pharm Des. 2021;27(1):80-90. PMID: 32386485", "BibTeX": "@article{32386485, title={Novel Targets of Metformin in Cardioprotection: Beyond the Effects Mediated by AMPK.}, author={Bolívar S and Noriega L and Ortega S and Osorio E and Rosales W and Mendoza X and Mendoza-Torres E}, journal={Curr Pharm Des}, volume={27}, number={1}, pages={80-90}}"}}, {"_id": "32556103", "pmid": 32556103, "title": "Metformin alleviates hyperuricaemia-induced serum FFA elevation and insulin resistance by inhibiting adipocyte hypertrophy and reversing suppressed white adipose tissue beiging.", "journal": "Clin Sci (Lond)", "authors": ["Su M", "Sun L", "Li W", "Liu H", "Liu Y", "Wei Y", "Yuan Y", "Zheng L", "Yin S", "Dai C", "Zhao C", "Pan Z", "Li Y"], "date": "2020-06-26T00:00:00Z", "doi": "10.1042/CS20200580", "meta_date_publication": "2020 Jun 26", "meta_volume": "134", "meta_issue": "12", "meta_pages": "1537-1553", "score": 50250.34, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ alleviates hyperuricaemia-induced serum @CHEMICAL_Fatty_Acids_Nonesterified @CHEMICAL_MESH:D005230 @@@FFA@@@ elevation and @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ by inhibiting @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@adipocyte hypertrophy@@@ and reversing suppressed white adipose tissue beiging.", "citations": {"NLM": "Su M, Sun L, Li W, Liu H, Liu Y, Wei Y, Yuan Y, Zheng L, Yin S, Dai C, Zhao C, Pan Z, Li Y. Metformin alleviates hyperuricaemia-induced serum FFA elevation and insulin resistance by inhibiting adipocyte hypertrophy and reversing suppressed white adipose tissue beiging. Clin Sci (Lond). 2020 Jun 26;134(12):1537-1553. PMID: 32556103", "BibTeX": "@article{32556103, title={Metformin alleviates hyperuricaemia-induced serum FFA elevation and insulin resistance by inhibiting adipocyte hypertrophy and reversing suppressed white adipose tissue beiging.}, author={Su M and Sun L and Li W and Liu H and Liu Y and Wei Y and Yuan Y and Zheng L and Yin S and Dai C and Zhao C and Pan Z and Li Y}, journal={Clin Sci (Lond)}, volume={134}, number={12}, pages={1537-1553}}"}}, {"_id": "34775284", "pmid": 34775284, "title": "Morphological and functional characterization of diabetic cardiomyopathy in db/db mice following exercise, metformin alone, or combination treatments.", "journal": "Biochem Biophys Res Commun", "authors": ["Lu J", "Liu J", "Zhang L", "Wang X", "Zhang Y", "Tang Q"], "date": "2021-12-20T00:00:00Z", "doi": "10.1016/j.bbrc.2021.11.018", "meta_date_publication": "2021 Dec 20", "meta_volume": "584", "meta_issue": "", "meta_pages": "80-86", "score": 50250.17, "text_hl": "In conclusion, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ improved changes in the morphology and structure of the heart and aorta, while exercise alone or in combination with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ demonstrated more advantages in cardiac functional reserve through the physiological @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@hypertrophy of myocardium@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ db/db @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Lu J, Liu J, Zhang L, Wang X, Zhang Y, Tang Q. Morphological and functional characterization of diabetic cardiomyopathy in db/db mice following exercise, metformin alone, or combination treatments. Biochem Biophys Res Commun. 2021 Dec 20;584():80-86. PMID: 34775284", "BibTeX": "@article{34775284, title={Morphological and functional characterization of diabetic cardiomyopathy in db/db mice following exercise, metformin alone, or combination treatments.}, author={Lu J and Liu J and Zhang L and Wang X and Zhang Y and Tang Q}, journal={Biochem Biophys Res Commun}, volume={584}, pages={80-86}}"}}, {"_id": "31711850", "pmid": 31711850, "title": "Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension.", "journal": "Int J Cardiol", "authors": ["Gu J", "Yin ZF", "Zhang JF", "Wang CQ"], "date": "2020-05-01T00:00:00Z", "doi": "10.1016/j.ijcard.2019.11.087", "meta_date_publication": "2020 May 1", "meta_volume": "306", "meta_issue": "", "meta_pages": "140-145", "score": 50244.566, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ also generated more prominent improvement in left ventricular (LV) diastolic function and @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@hypertrophy@@@. ", "citations": {"NLM": "Gu J, Yin ZF, Zhang JF, Wang CQ. Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension. Int J Cardiol. 2020 May 1;306():140-145. PMID: 31711850", "BibTeX": "@article{31711850, title={Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension.}, author={Gu J and Yin ZF and Zhang JF and Wang CQ}, journal={Int J Cardiol}, volume={306}, pages={140-145}}"}}, {"_id": "34384564", "pmid": 34384564, "title": "Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.", "journal": "J Pharmacol Sci", "authors": ["Sunagawa Y", "Shimizu K", "Katayama A", "Funamoto M", "Shimizu K", "Nurmila S", "Shimizu S", "Miyazaki Y", "Katanasaka Y", "Hasegawa K", "Morimoto T"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.jphs.2021.07.001", "meta_date_publication": "2021 Oct", "meta_volume": "147", "meta_issue": "2", "meta_pages": "169-175", "score": 50244.18, "text_hl": "These @CHEMICAL_Phenylephrine @CHEMICAL_MESH:D010656 @@@PE@@@-induced changes were inhibited by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. Next, to examine the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @GENE_EP300 @GENE_2033 @@@p300@@@-mediated @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@hypertrophy@@@, cardiomyocytes were transfected with expression vector of @GENE_EP300 @GENE_2033 @@@p300@@@. ", "citations": {"NLM": "Sunagawa Y, Shimizu K, Katayama A, Funamoto M, Shimizu K, Nurmila S, Shimizu S, Miyazaki Y, Katanasaka Y, Hasegawa K, Morimoto T. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes. J Pharmacol Sci. 2021 Oct;147(2):169-175. PMID: 34384564", "BibTeX": "@article{34384564, title={Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.}, author={Sunagawa Y and Shimizu K and Katayama A and Funamoto M and Shimizu K and Nurmila S and Shimizu S and Miyazaki Y and Katanasaka Y and Hasegawa K and Morimoto T}, journal={J Pharmacol Sci}, volume={147}, number={2}, pages={169-175}}"}}, {"_id": "32462317", "pmid": 32462317, "title": "Hesperidin ameliorates signs of the metabolic syndrome and cardiac dysfunction via IRS/Akt/GLUT4 signaling pathway in a rat model of diet-induced metabolic syndrome.", "journal": "Eur J Nutr", "authors": ["Prasatthong P", "Meephat S", "Rattanakanokchai S", "Bunbupha S", "Prachaney P", "Maneesai P", "Pakdeechote P"], "date": "2021-03-01T00:00:00Z", "doi": "10.1007/s00394-020-02291-4", "meta_date_publication": "2021 Mar", "meta_volume": "60", "meta_issue": "2", "meta_pages": "833-848", "score": 50244.043, "text_hl": "@CHEMICAL_Hesperidin @CHEMICAL_MESH:D006569 @@@Hesperidin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ improved @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@cardiac dysfunction@@@ and @<m>DISEASE_Hypertrophy</m> @DISEASE_MESH:D006984 @@@hypertrophy@@@ observed in @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@MS@@@ @SPECIES_10116 @@@rats@@@ (p < 0.05). ", "citations": {"NLM": "Prasatthong P, Meephat S, Rattanakanokchai S, Bunbupha S, Prachaney P, Maneesai P, Pakdeechote P. Hesperidin ameliorates signs of the metabolic syndrome and cardiac dysfunction via IRS/Akt/GLUT4 signaling pathway in a rat model of diet-induced metabolic syndrome. Eur J Nutr. 2021 Mar;60(2):833-848. PMID: 32462317", "BibTeX": "@article{32462317, title={Hesperidin ameliorates signs of the metabolic syndrome and cardiac dysfunction via IRS/Akt/GLUT4 signaling pathway in a rat model of diet-induced metabolic syndrome.}, author={Prasatthong P and Meephat S and Rattanakanokchai S and Bunbupha S and Prachaney P and Maneesai P and Pakdeechote P}, journal={Eur J Nutr}, volume={60}, number={2}, pages={833-848}}"}}]}